Free Internal Medicine CME

  • FREE

    CME: Ulcerative Colitis: Updates from the DDW 2019 Annual Meeting

    IBD is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are ulcerative colitis (UC) and Crohn’s disease, the former of which exclusively affects the colon and rectum. Guidelines exist for the treatment of UC, but they are constantly changing to include updated information. Despite the plethora of guidelines available, there are issues surrounding guideline adherence by physicians, patient satisfaction, the quality of treatment and a patient’s QOL. Given the data from multiple studies that physicians are either not aware of updated practice guidelines or are not utilizing them, that this lack of knowledge is affecting patient satisfaction, and that there may be demographically-based barriers to care, educational activities are warranted to keep HCPs abreast of best practices in patients with UC. This activity has been designed to review treatment strategies, emerging therapies, and gaps in care of patients with UC.

    By the end of the session the participant will be able to:

    • Describe long-term outcomes of UC patients with dysplasia who undergo endoscopic resection and surveillance and apply that information to a patient case
    • Describe the effect of endoscopic and histologic remission as treatment targets
    • Describe the risk of biologic therapy use in special populations, such as elderly and surgical patients and apply that information to a patient case
    • Recall emerging data on biologic drug safety and efficacy

    Target Audience:

    Healthcare professionals specializing in: gastroenterology, internal medicine, and those who otherwise commonly care for patients with UC.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 9/23/19
    • Expiration of CME credit: 9/23/21
  • FREE

    CME: Prevention and management of influenza infection

    Influenza has been recognized as a global public health menace since at least 100 years ago with the 1918-19 pandemic, which infected an estimated one-third of the world’s population and was responsible for the deaths of one in ten, or 50 million, of those infected. While some have contended that a significant number of deaths associated with the 1918 pandemic may have actually been attributable to acid-base derangements and pulmonary edema associated with contemporary aspirin dosing in the toxic range of two to eight times what is presently the maximum recommended dose – it remains a significant public health concern, with the 2017-2018 flu season in recent decades with an estimated 80,000 deaths (typical range 12,000-56,000 per year),coming with an annual cost of $16 billion.

    By the end of the session the participant will be able to:

    • Determine the impact of influenza infection
    • Describe influenza vaccination recommendations and apply them to patient cases
    • Describe treatment recommendations and apply them to patient cases
    • Describe present challenges to the prevention and treatment of influenza and develop strategies to combat them

    Target Audience:

    Healthcare professionals specializing in: infectious disease, internal medicine, and pediatrics; physician assistants, nurse practitioners, nurses, and pharmacists who specialize in the aforementioned areas; and any other healthcare professionals with an interest in or who clinically encounter patients with influenza.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 7/23/19
    • Expiration of CME credit: 7/23/21